课题基金 / 基金详情

Core_plus_Option_A_B_Proposal for Influenza Vaccine Effectiveness Research

Core_plus_Option_A_B_Proposal for Influenza Vaccine Effectiveness Research
Core_plus_Option_A_B_流感疫苗有效性研究提案
批准号:
8874763
负责人:
ARNOLD S MONTO
金额:
$141.38万
依托单位国家:
美国
项目类别:
财政年份:
2011
资助国家:
美国
项目状态:
已结题
起止时间:
2011-07-01 至 2016-07-31

项目摘要

项目成果

ARNOLD S MONTO的其他基金

相似基金

相关文献

中文摘要
翻译
点击翻译按钮获取中文摘要
英文摘要
DESCRIPTION (provided by applicant): Because of near universal recommendation for annual vaccination (all aged 6 months) only observational studies of influenza vaccine effectiveness can be performed for ethical reasons. However, results from observational studies may be subject to unrecognized selection biases, and study design strategies to identify and adjust for these biases are necessary. We propose estimation of influenza vaccine effectiveness in preventing medically attended influenza in two health systems, and influenza of all severities in a cohort of households with children, in Michigan. We will conduct surveillance at multiple outpatient health centers, three hospitals, and in ~300 enrolled households during the influenza season, and will enroll adult and pediatric patients and household members meeting various case definitions. Vaccination status will be reported and validated, and considered with laboratory-confirmed influenza outcomes to estimate vaccine effectiveness separately for ambulatory, inpatient and household populations, with estimates compared across studies. Analyses will use a test-negative control approach-those testing positive for influenza are cases, those testing negative are controls. Modifiers and confounders of vaccine effectiveness such as age, health status, household size and composition, health care utilization, subjective socio-economic status, and health system characteristics will be assessed and considered in analytic models.
期刊论文(0)
专著(0)
科研奖励(0)
会议论文
US Influenza Vaccine Effectiveness Network
US Influenza Vaccine Effectiveness Network
US Influenza Vaccine Effectiveness Network
US Hospital Vaccine Effectiveness (VE) Network - Supplement
海外基金